Re-exposing Patients to Heparin After Heparin-Induced Thrombocytopenia – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Elizabeth B. Caudill et al., adding:
”Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
This single-center retrospective study followed 35 patients with prior heparin-induced thrombocytopenia who were re-exposed to heparin products.
Only one (2.9 percent) developed recurrent HIT, with no associated thrombosis, bleeding, or in-hospital mortality. Median interval from HIT diagnosis to re-exposure was 8.1 years, suggesting re-exposure may be safe in remote HIT.”
Title: Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
Authors: Elizabeth B. Caudill, Ju Hee Kim, Dareen M. Kanaan, Katelyn W. Sylvester, Liriany Y. Pimentel, Christine S. Kim, Jean M. Connors
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026
-
Oct 18, 2026, 15:17Alexey Kulikov: Could Platelets Reveal Frailty Before Physical Signs Appear?
-
Oct 18, 2026, 15:06Elisa Rossi: Advancing HHT Research at the 16th International Conference
-
Oct 18, 2026, 14:58Aishwarya Dash: Simplifying Bone Marrow Mesenchymal Stromal Cell Isolation
-
Oct 18, 2026, 14:54Caitlin Raymond: Could the Apheresis Circuit Itself Modulate Immunity?